How did Elizabeth Holmes's lack of honesty negatively affect her life?

Explanation:

Elizabeth Holmes appeared to know exactly what she needed to do. It was September 2017, and the situation was dire. Theranos, the blood-testing company that she had dreamed up more than a decade ago, during her freshman year at Stanford, was imploding before her very eyes. John Carreyrou, an investigative reporter at The Wall Street Journal, had spent nearly two years detailing the start-up’s various misdeeds—questioning the veracity of its lab results and the legitimacy of its core product, the Edison, a small, consumer blood-testing device that supposedly used a drop of blood to perform hundreds of medical tests. Carreyrou had even revealed that Theranos relied on third-party devices to administer its own tests. Theranos, which had raised nearly $1 billion in funding for a valuation estimated at around $9 billion, now appeared less a medical-sciences company than a house of cards.

Owing largely to Carreyrou’s reporting, the fallout had been colossal, unprecedented. Theranos was under investigation by the Securities and Exchange Commission, the Department of Justice, and the Federal Bureau of Investigation. It had been sued by investors. Walgreens, its largest partner, terminated the relationship and shut down 40 testing sites. Forbes, which once estimated Holmes’s wealth at $4.5 billion, wrote it down to zero. The young founder, who was once compared to Steve Jobs, had recently been dubbed a “millennial Madoff” by the New York Post. According to two former executives at the company, Theranos had as many as nine different law firms on retainer, including the formidable Boies Schiller Flexner, to handle the mess—what appeared to be the end of a long, labored, highly visible, and heinous corporate death march.